Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment | MicrobiomeTrials← Back to trialsNCT06279013
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-10-14Est. Completion: 2027-02-01
Enrollment target: 600 participants Locations- Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
- CARTI Cancer Center, Little Rock, Arkansas, United States
- Phoebe Putney Memorial Hospital, Albany, Georgia, United States
- Augusta Oncology Associates PC-D'Antignac, Augusta, Georgia, United States
- Augusta University Medical Center, Augusta, Georgia, United States
- Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States
- Queen's Medical Center, Honolulu, Hawaii, United States
- Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States
- The Queen's Medical Center - West Oahu, ‘Ewa Beach, Hawaii, United States
- John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
- Carle at The Riverfront, Danville, Illinois, United States
- Carle Physician Group-Effingham, Effingham, Illinois, United States
- Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States
- Carle Cancer Center, Urbana, Illinois, United States
- Central Care Cancer Center - Garden City, Garden City, Kansas, United States
- University Medical Center New Orleans, New Orleans, Louisiana, United States
Other microbiome trials you might be interested in
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia, Myelodysplasia-RelatedMyelodysplastic Syndrome
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific lab…
Birmingham, United StatesEst. completion May 15, 2029
Lake Regional Hospital, Osage Beach, Missouri, United StatesUniversity of New Mexico Cancer Center, Albuquerque, New Mexico, United StatesAnMed Health Cancer Center, Anderson, South Carolina, United StatesMedical University of South Carolina, Charleston, South Carolina, United StatesPrisma Health Cancer Institute - Butternut, Greenville, South Carolina, United StatesPrisma Health Cancer Institute - Faris, Greenville, South Carolina, United StatesPrisma Health Greenville Memorial Hospital, Greenville, South Carolina, United StatesPrisma Health Cancer Institute - Eastside, Greenville, South Carolina, United StatesLanglade Hospital and Cancer Center, Antigo, Wisconsin, United StatesAspirus Medford Hospital, Medford, Wisconsin, United StatesAspirus Cancer Care - James Beck Cancer Center, Rhinelander, Wisconsin, United StatesAspirus Cancer Care - Stevens Point, Stevens Point, Wisconsin, United StatesAspirus Regional Cancer Center, Wausau, Wisconsin, United StatesAspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids, Wisconsin, United StatesPuerto Rico Hematology Oncology Group, Bayamón, Puerto RicoDoctors Cancer Center, Manati, Puerto RicoCentro Comprensivo de Cancer de UPR, San Juan, Puerto RicoPROncology, San Juan, Puerto RicoAcute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Acute Biphenotypic Leukemia
Acute Undifferentiated Leukemia
CLL (Chronic Lymphocytic Leukemia)
Chronic Myeloid Leukemia (CML)
MDS (Myelodysplastic Syndrome)
Non-Hodgkin Lymphomas
Hodgkins Lymphoma
Cutaneous T Cell Lymphomas (CTCL)
The goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marro…
Duarte, United StatesEst. completion Jul 14, 2026
GATA2ImmunodeficiencyMDS
Background:
\- GATA2 deficiency is a disease caused by mutations in the GATA2 gene. It can cause different types of leu…
Bethesda, United StatesEst. completion Dec 31, 2027